These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9747348)

  • 21. Mechanism of antimicrobial resistance and resistance transfer in anaerobic bacteria.
    Tally FP; Malamy MH
    Scand J Infect Dis Suppl; 1982; 35():37-44. PubMed ID: 6300995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989.
    Cuchural GJ; Snydman DR; McDermott L; Iannini PB; Hill GB; Cleary TJ; O'Keefe JP; Pierson CL; Rihs JD; Finegold SM
    Clin Ther; 1992; 14(1):122-36. PubMed ID: 1576621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of resistance in Bacteroides fragilis strains according to recent Brazilian profiles of antimicrobial susceptibility.
    Paula GR; Falcão LS; Antunes EN; Avelar KE; Reis FN; Maluhy MA; Ferreira MC; Domingues RM
    Int J Antimicrob Agents; 2004 Jul; 24(1):53-8. PubMed ID: 15225862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance to tetracycline, erythromycin, and clindamycin in the Bacteroides fragilis group: inducible versus constitutive tetracycline resistance.
    Privitera G; Fayolle F; Sebald M
    Antimicrob Agents Chemother; 1981 Sep; 20(3):314-20. PubMed ID: 7305321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A site-specific DNA inversion in Bacteroides plasmid pBF4 is influenced by the presence of the conjugal tetracycline resistance element.
    Matthews BG; Roudier C; Guiney DG
    J Bacteriol; 1991 Aug; 173(16):5239-43. PubMed ID: 1650348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance factors in anaerobic bacteria.
    Tally FP; Malamy MH
    Scand J Infect Dis Suppl; 1986; 49():56-63. PubMed ID: 3029859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF.
    Treviño M; Areses P; Peñalver MD; Cortizo S; Pardo F; del Molino ML; García-Riestra C; Hernández M; Llovo J; Regueiro BJ
    Anaerobe; 2012 Feb; 18(1):37-43. PubMed ID: 22261518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmid analysis of clinical isolates of Bacteroides fragilis group strains.
    Nagy E; Dányi E; Földes J
    Acta Microbiol Hung; 1990; 37(4):367-73. PubMed ID: 2099083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of antibiotic resistant strains of Bacteroides fragilis.
    Scher KS
    Surg Gynecol Obstet; 1988 Sep; 167(3):175-9. PubMed ID: 3413646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newer beta-lactam agents and the Bacteroides fragilis group.
    Cuchural GJ
    Pharmacotherapy; 1991; 11(2 ( Pt 2)):51S-55S. PubMed ID: 2041832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial resistance and plasmid detection in strains of the Bacteroides fragilis group.
    Avila-Campos MJ; de Carvalho MA; Magalhäes PP; Damasceno CA; Chartone-Souza E; Cisalpino EO
    Rev Inst Med Trop Sao Paulo; 1993; 35(1):107-10. PubMed ID: 8278739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of antimicrobial resistance patterns of enterotoxin gene positive and negative Bacteroides fragilis isolates].
    Toprak NU; Yağci A; Celik C; Cakici O; Söyletir G
    Mikrobiyol Bul; 2005 Apr; 39(2):145-52. PubMed ID: 16128024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)].
    Tytgat F
    Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
    Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Lee K; Kim JM; Chong Y
    Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug resistance of bacteria and countermeasures--current status of resistance. 5. Anaerobic bacteria].
    Watanabe K; Ueno K
    Nihon Rinsho; 1986 Apr; 44(4):982-6. PubMed ID: 3761600
    [No Abstract]   [Full Text] [Related]  

  • 36. Bacteroides fragilis group: trends in resistance.
    Fille M; Mango M; Lechner M; Schaumann R
    Curr Microbiol; 2006 Feb; 52(2):153-7. PubMed ID: 16450067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro antibiotic susceptibility and molecular analysis of anaerobic bacteria isolated in Cape Town, South Africa.
    Koch CL; Derby P; Abratt VR
    J Antimicrob Chemother; 1998 Aug; 42(2):245-8. PubMed ID: 9738844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of drug-resistance transfer in Bacteroides fragilis.
    Malamy MH; Tally FP
    J Antimicrob Chemother; 1981 Dec; 8 Suppl D():59-75. PubMed ID: 7040329
    [No Abstract]   [Full Text] [Related]  

  • 39. Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992.
    Dubreuil L; Breuil J; Dublanchet A; Sedallian A
    Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1094-9. PubMed ID: 1295764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occurrence of metronidazole and imipenem resistance among Bacteroides fragilis group clinical isolates in Hungary.
    Nagy E; Sóki J; Urban E; Szoke I; Fodor E; Edwards R
    Acta Biol Hung; 2001; 52(2-3):271-80. PubMed ID: 11426861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.